Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?

PubWeight™: 2.29‹?› | Rank: Top 2%

🔗 View Article (PMID 9779694)

Published in J Clin Oncol on October 01, 1998

Authors

C Ripamonti1, L Groff, C Brunelli, D Polastri, A Stavrakis, F De Conno

Author Affiliations

1: Pain Therapy and Palliative Care Division, National Cancer Institute, Milan, Italy. tdpint@tin.it

Associated clinical trials:

Development and Evaluation of a Methadone Protocol for Severe Chronic Pain Management | NCT02335398

Articles citing this

Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain (2009) 9.36

Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer (2001) 3.40

Establishing "best practices" for opioid rotation: conclusions of an expert panel. J Pain Symptom Manage (2009) 1.96

Methadone: applied pharmacology and use as adjunctive treatment in chronic pain. Postgrad Med J (2004) 1.22

Current aproach to cancer pain management: Availability and implications of different treatment options. Ther Clin Risk Manag (2007) 1.17

Switching from methadone to a different opioid: what is the equianalgesic dose ratio? J Palliat Med (2008) 1.12

Bioavailabilities of rectal and oral methadone in healthy subjects. Br J Clin Pharmacol (2004) 0.97

Recent advances in the use of opioids for cancer pain. J Pain Res (2009) 0.95

Methadone initiation and rotation in the outpatient setting for patients with cancer pain. Cancer (2010) 0.88

Use of methadone for prevention of opioid withdrawal in critically ill children. Can J Hosp Pharm (2012) 0.86

Optimizing use of opiates in the management of cancer pain. Ther Clin Risk Manag (2006) 0.84

Pain management in patients with cancer: focus on opioid analgesics. Curr Pain Headache Rep (2011) 0.83

Opioid plasma concentration during switching from morphine to methadone: preliminary data. Support Care Cancer (2003) 0.82

The role of methadone in opioid rotation-a Polish experience. Support Care Cancer (2008) 0.82

Chronic methadone treatment and repeated withdrawal impair cognition and increase the expression of apoptosis-related proteins in mouse brain. Psychopharmacology (Berl) (2007) 0.82

Practicability, safety, and efficacy of a "German model" for opioid conversion to oral levo-methadone. Support Care Cancer (2011) 0.82

Contribution to variability in response to opioids. Support Care Cancer (2004) 0.81

A review of common methods to convert morphine to methadone. J Community Hosp Intern Med Perspect (2013) 0.80

Methadone: the question or the answer for US opioid therapy and pharmaco-economics? Support Care Cancer (2001) 0.79

Efficacy of opioid rotation to continuous parenteral hydromorphone in advanced cancer patients failing on other opioids. Support Care Cancer (2011) 0.79

Pharmacological strategies for the management of cancer pain in developing countries. Pharm Pract (Granada) (2007) 0.78

Serum concentrations of opioids when comparing two switching strategies to methadone for cancer pain. Eur J Clin Pharmacol (2012) 0.78

[Accidental levomethadone intoxication in a palliative patient]. Schmerz (2012) 0.78

[Opioids for cancer pain treatment. Efficacy and side effects]. Schmerz (2005) 0.77

Use of methadone. West J Med (2000) 0.77

Intravenous Methadone for Severe Cancer Pain: A Presentation of 10 Cases. ISRN Pain (2012) 0.76

Early switching from morphine to methadone is not improved by acetaminophen in the analgesia of oncologic patients: a prospective, randomized, double-blind, placebo-controlled study. Support Care Cancer (2009) 0.75

Methadone in cancer pain management: individualize dose and titrate to effect. J Clin Oncol (1998) 0.75

Doctor Shopping Behavior and the Diversion of Prescription Opioids. Subst Abuse (2017) 0.75

Switching from oxycodone to methadone in advanced cancer patients. Support Care Cancer (2011) 0.75

Efficacy and Safety of Methadone as a Second-Line Opioid for Cancer Pain in an Outpatient Clinic: A Prospective Open-Label Study. Oncologist (2016) 0.75

The poor use of methadone in Italian hospices. Support Care Cancer (2013) 0.75

Articles by these authors

Quality-of-life assessment during a palliative care programme. Ann Oncol (1990) 2.67

A validation study of the WHO method for cancer pain relief. Cancer (1987) 2.32

Symptom prevalence and control during cancer patients' last days of life. J Palliat Care (1990) 2.22

[Cost analysis for DRG and PRG in the treatment of acute myocardial infarction in hospitalized patients]. G Ital Cardiol (1997) 1.92

Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain. J Pain Symptom Manage (1999) 1.80

Attitudes toward euthanasia of physician members of the Italian Society for Palliative Care. Ann Oncol (1996) 1.71

Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey. Palliat Med (2004) 1.71

Ultrasound biomicroscopic and conventional ultrasonographic study of ocular dimensions in primary angle-closure glaucoma. Ophthalmology (1998) 1.64

Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan. Ann Oncol (2008) 1.56

Relationship between vitamin D status and left ventricular geometry in a healthy population: results from the Baltimore Longitudinal Study of Aging. J Intern Med (2012) 1.54

Sequence of events in angina at rest: primary reduction in coronary flow. Circulation (1980) 1.51

Morphine for relief of cancer pain. Lancet (1996) 1.47

Total rectal resection and complete mesorectum excision followed by coloendoanal anastomosis as the optimal treatment for low rectal cancer: the experience of the National Cancer Institute of Milano. Ann Surg Oncol (2000) 1.45

Trends in opioid analgesics sales to community pharmacies and hospitals in Italy (2000-2010). Minerva Anestesiol (2013) 1.39

Visual disturbances in advanced cancer patients: clinical observations. J Pain Symptom Manage (1999) 1.39

Impairment of myocardial perfusion and function during painless myocardial ischemia. J Am Coll Cardiol (1983) 1.35

Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care Cancer (2001) 1.32

Quality of life assessment and outcome of palliative care. J Pain Symptom Manage (2001) 1.24

Impact of delirium on the short term prognosis of advanced cancer patients. Italian Multicenter Study Group on Palliative Care. Cancer (2000) 1.21

WHO guidelines for the use of analgesics in cancer pain. Int J Tissue React (1985) 1.18

Ultrasound biomicroscopy and intraocular-pressure-lowering mechanisms of deep sclerectomy with reticulated hyaluronic acid implant. J Cataract Refract Surg (2001) 1.18

Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. J Clin Oncol (2001) 1.17

Assessment of hospitalised cancer patients' needs by the Needs Evaluation Questionnaire. Ann Oncol (2000) 1.13

Terminal cancer patients and timing of referral to palliative care: a multicenter prospective cohort study. Italian Cooperative Research Group on Palliative Medicine. J Pain Symptom Manage (1999) 1.10

A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation. Cancer (1998) 1.08

Characteristics of terminal cancer patients who committed suicide during a home palliative care program. J Pain Symptom Manage (2001) 1.06

Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial. J Pain Symptom Manage (2000) 1.04

Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients. J Clin Oncol (1996) 1.04

Management of bowel obstruction in advanced and terminal cancer patients. Ann Oncol (1993) 1.01

Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction. Support Care Cancer (2000) 1.00

Ultrasound biomicroscopy and corneal endothelium in Nd:YAG-laser iridotomy. Ophthalmic Surg Lasers (1996) 1.00

Pain measurement in cancer patients: a comparison of six methods. Pain (1994) 0.99

Assessing delirium in cancer patients: the Italian versions of the Delirium Rating Scale and the Memorial Delirium Assessment Scale. J Pain Symptom Manage (2001) 0.99

Effect of home care on the place of death of advanced cancer patients. Eur J Cancer (1996) 0.98

Antidepressants increase bioavailability of morphine in cancer patients. Lancet (1987) 0.98

Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure. Eur J Clin Invest (2003) 0.96

Megestrol acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial. Eur J Cancer (1998) 0.95

Sodium naproxen versus sodium diclofenac in cancer pain control. Arzneimittelforschung (1990) 0.95

The management of inoperable gastrointestinal obstruction in terminal cancer patients. Tumori (1990) 0.94

Efficacy of homeopathic treatment of skin reactions during radiotherapy for breast cancer: a randomised, double-blind clinical trial. Br Homeopath J (2000) 0.94

Home palliative care for terminal cancer patients: a survey on the final week of life. Palliat Med (1999) 0.94

Left ventricular geometry and function in patients with essential hypertension and microalbuminuria. J Hypertens (1999) 0.94

Detection of acute myocardial infarction by 99mTc-labeled D-glucaric acid imaging in patients with acute chest pain. J Nucl Med (1999) 0.92

Increased fibrinopeptide A formation and thromboxane A2 production in patients with ischemic heart disease: relationships to coronary pathoanatomy, risk factors, and clinical manifestations. Am Heart J (1981) 0.92

Guidelines on artificial nutrition versus hydration in terminal cancer patients. European Association for Palliative Care. Nutrition (1996) 0.92

Ultrasonography of arm edema after axillary dissection for breast cancer: a preliminary study. Lymphology (2001) 0.92

Insulin-like growth factor-I and angiographically documented coronary artery disease. Am J Cardiol (1996) 0.91

Palliative care research. Eur J Cancer (2001) 0.91

Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences. Ann Oncol (1998) 0.91

Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction. J Pain Symptom Manage (1991) 0.91

Suicide among patients with cancer cared for at home by palliative-care teams. Lancet (1999) 0.89

A randomized study on oral administration of morphine and methadone in the treatment of cancer pain. J Pain Symptom Manage (1986) 0.89

Oral complications in patients with advanced cancer. J Palliat Care (1989) 0.89

The role of somatostatin and octreotide in bowel obstruction: pre-clinical and clinical results. Tumori (2001) 0.88

Comparison of home and hospital care of advanced cancer patients. Tumori (1989) 0.88

Trazodone for deafferentation pain. Comparison with amitriptyline. Psychopharmacology (Berl) (1988) 0.88

Propofol in terminal care. J Pain Symptom Manage (1995) 0.87

N-acetyl-cysteine reduces neointimal thickening and procoagulant activity after balloon-induced injury in abdominal aortae of New Zealand white rabbits. Thromb Haemost (2001) 0.86

Pain experienced by patients hospitalized at the National Cancer Institute of Milan: research project "towards a pain-free hospital". Tumori (2000) 0.85

Is target opioid therapy within sight? Minerva Anestesiol (2012) 0.84

End-of-life preferences in advanced cancer patients willing to discuss issues surrounding their terminal condition. Eur J Cancer Care (Engl) (2012) 0.84

Studies on the effects of antidepressant drugs on the antinociceptive action of morphine and on plasma morphine in rat and man. Pain (1990) 0.84

The relationship between visceral adiposity and left ventricular diastolic function: results from the Baltimore Longitudinal Study of Aging. Nutr Metab Cardiovasc Dis (2013) 0.83

Prognostic value of quality of life scores in terminal cancer patients. J Pain Symptom Manage (1996) 0.83

On the significance of Lhermitte's sign in oncology. J Neurooncol (1991) 0.83

The patient's perception of his own quality of life might have an adjunctive prognostic significance in lung cancer. Lung Cancer (1995) 0.82

Side effects of morphine administration in cancer patients. Cancer Nurs (1998) 0.82

A therapy impact questionnaire for quality-of-life assessment in advanced cancer research. Ann Oncol (1992) 0.81

Continuous subcutaneous infusion of ketorolac in cancer neuropathic pain unresponsive to opioid and adjuvant drugs. A case report. Tumori (1996) 0.80

How to evaluate the effect of pain treatments in cancer patients: results from a longitudinal outcomes and endpoint Italian cohort study. Eur J Pain (2012) 0.79

Content development for EUROPEAN GUIDELINES on the use of opioids for cancer pain: a systematic review and Expert Consensus Study. Minerva Anestesiol (2010) 0.79

A retrospective study on the use of oral morphine in cancer pain. J Pain Symptom Manage (1987) 0.79

Pain treatment in cancer of the pancreas. Eur J Surg Oncol (1990) 0.79

Sulfonylurea treatment of type 2 diabetic patients does not reduce the vasodilator response to ischemia. Diabetes Care (2001) 0.79

The difficult choice of chemotherapy in patients with unresectable non-small-cell lung cancer. Support Care Cancer (2000) 0.79

Organizing pain control and rehabilitation service in a cancer centre. Int Rehabil Med (1981) 0.79

The psychological impact of breast and ovarian cancer preventive options in BRCA1 and BRCA2 mutation carriers. Clin Genet (2013) 0.79

Comparison of low-dose aspirin and coronary vasodilators in acute unstable angina. Circulation (1990) 0.78

Rectal methadone in cancer patients with pain. A preliminary clinical and pharmacokinetic study. Ann Oncol (1995) 0.78

Perfusion-contraction mismatch during inotropic stimulation in hibernating myocardium. J Nucl Med (1998) 0.78

Neurotoxicity of interferon-alpha in melanoma therapy: results from a randomized controlled trial. Cancer (1998) 0.78

Variable threshold of exertional angina: a clue to a vasospastic component. Eur Heart J (1981) 0.78

Contrast harmonic color Doppler left ventriculography: machine-interpreted left ventricular ejection fraction compared with equilibrium-gated radionuclide ventriculography. J Am Soc Echocardiogr (2000) 0.78

Skin problems in advanced and terminal cancer patients. J Pain Symptom Manage (1991) 0.78

Ketorolac versus diclofenac sodium in cancer pain. Arzneimittelforschung (1994) 0.78

The role of disodium pamidronate in the management of bone pain due to malignancy. Palliat Med (2001) 0.77

Organic brain syndromes and opioid administration for cancer pain. J Pain Symptom Manage (1994) 0.77

[Selection of candidates for cardiac resynchronisation therapy and prediction of their response.]. Clin Ter (2010) 0.77

Role of enteral nutrition in advanced cancer patients: indications and contraindications of the different techniques employed. Tumori (1996) 0.77

The feasibility of repetitive courses of high-dose continuous intravenous infusion interleukin-2 and subcutaneous alpha-interferon with polychemotherapy in advanced malignant melanoma. Tumori (1995) 0.77